Short answer
A cochlear implant is a surgically implanted electronic device that bypasses damaged parts of the inner ear and stimulates the hearing (auditory) nerve directly.1 It may help people with severe-to-profound hearing loss who gain little from well-fitted hearing aids to detect sound and, with practice, understand speech. It does not restore normal hearing, and results range from near-normal speech understanding to no useful benefit.3 Suitability depends on the cause, inner-ear and nerve anatomy, how long the loss has lasted and lifelong access to programming, which is why specialist team assessment matters.
Decision snapshot
| Question | Snapshot |
|---|---|
| Main purpose | Access to sound and speech when hearing aids no longer give enough benefit |
| Typical candidate | Severe-to-profound sensorineural hearing loss with limited hearing-aid benefit, after specialist assessment |
| Anaesthesia | General anaesthesia; surgery of about two hours12 |
| Switch-on | Usually two to four weeks after surgery1112 |
| Time to benefit | Months of listening practice; programming continues for life |
| Key limitation | Highly variable outcome; not natural hearing; may remove remaining hearing in the implanted ear |
| Lifelong needs | Programming, repairs, processor replacement, MRI precautions |
On this page
- How a cochlear implant works
- What may be causing the hearing loss
- Who may be considered
- Alternatives
- Evaluation, surgery and anaesthesia
- Activation, mapping and results timeline
- How long the implant lasts
- Pain and comfort
- Risks and complications
- How strong is the evidence?
- MRI and device distinctions
- Cost drivers
- Frequently asked questions
- Bottom line
- Sources
How a cochlear implant works
A hearing aid makes sound louder. A cochlear implant works differently: it turns sound into electrical signals and delivers them to the auditory nerve, bypassing the damaged sensory cells of the cochlea (the snail-shaped hearing organ of the inner ear).1 The brain then has to learn to interpret those signals as sound.
- External sound processor: a microphone and processor code the sound, and a transmitter coil, held by a magnet, passes it through the skin.
- Internal implant: a receiver-stimulator under the skin behind the ear feeds a thin electrode array inside the cochlea; each electrode stimulates a different region of the nerve.
The result is not the same as natural hearing,2 and understanding improves with use, programming and auditory training.
What may be causing the hearing loss
Severe-to-profound hearing loss has many causes, and the cause shapes whether an implant can help. The WHO, the United Nations public-health agency, groups causes across the life course:9
- Before birth: genetic causes and infections in pregnancy such as rubella and cytomegalovirus (CMV).
- Around birth: lack of oxygen, severe newborn jaundice and low birth weight.
- Childhood: meningitis and other infections, and chronic middle-ear infection.
- Adulthood: age-related hearing loss, otosclerosis (abnormal bone growth in the middle ear), sudden sensorineural hearing loss and chronic disease.
- At any age: head trauma, loud noise, ototoxic medicines (drugs that can damage the ear), progressive genetic loss and viral infections.
Some causes, such as earwax impaction and many middle-ear problems, are treated in other ways.9 A cochlear implant relies on a working auditory nerve, so when the nerve is absent or badly damaged, for example after removal of tumours in neurofibromatosis type 2 (NF2), a different device may be discussed.15 Investigating the cause comes first.
What it may change
Who may be considered
Candidacy rules differ by country and describe who may be assessed, not who will benefit.
United Kingdom. The National Institute for Health and Care Excellence (NICE) technology appraisal TA566 (2019) recommends a single implant as an option for severe-to-profound deafness when acoustic hearing aids do not give adequate benefit.5 Severe-to-profound means hearing only sounds louder than 80 dB HL (decibels hearing level) at two or more of the tested frequencies in both ears without aids. For adults, adequate benefit means a phoneme score of 50% or more on the Arthur Boothroyd word test at 70 dBA (A-weighted decibels). For children, it means age-appropriate speech, language and listening skills. A hearing-aid trial of at least three months is expected unless inappropriate, and assessment must be by a multidisciplinary team. Implants in both ears at the same time are recommended for children and for adults who are blind or have other disabilities that increase reliance on hearing.5
United States. The Food and Drug Administration (FDA) approves indications device by device, in each manufacturer’s labelling.6 Labels use speech-recognition cut-offs (for example 50% or less on sentences in the ear to be implanted), and one manufacturer’s labelling includes single-sided deafness.6 Paediatric approvals have moved younger: from 9 months for eligible children since 2020,1 and a November 2025 supplement extending one system’s labelling to children from 7 months with profound bilateral loss.7 Off-label implantation is common in US practice.6
Who may not benefit or may face additional risk
- People with an absent or severely damaged auditory nerve.15
- Adults with a very long duration of severe-to-profound loss, who on average gain less, though the effect is weaker than it once was.8
- People with inner-ear malformations, who may face a higher meningitis risk.3
- Very elderly people, in whom anaesthetic events, vertigo and fall risk need closer attention.14
When a responsible clinician may advise against it
- When well-fitted hearing aids still give adequate benefit.
- When imaging shows no usable cochlea or nerve pathway.
- When reliable programming and rehabilitation cannot be arranged after surgery.
- When general health makes anaesthesia unsafe.
Alternatives
- Optimised hearing aids: refitting with modern aids is usually tried first; NICE expects a trial of at least three months.5
- Assistive listening devices: hearing loops, FM (radio) systems, captioned telephones and visual or vibrating alerts, used alone or alongside aids or implants.16
- Auditory brainstem implant (ABI): stimulates the brainstem directly, mainly for NF2 and, in investigational use, for some people whose nerve or cochlea cannot take a cochlear implant.15
- Visual communication: sign language, lipreading and captioning are complete communication routes in their own right.
No treatment is a legitimate option
Declining an implant is a valid choice. Many Deaf people use sign language, and others prefer hearing aids and assistive technology. For adults, the decision can be revisited later, although a long duration of deafness may reduce benefit.8
Evaluation, surgery and anaesthesia
Evaluation. In England, assessment covers audiology, medical, speech and language, psychological and information needs, and every case is discussed by a multidisciplinary team.13 Testing usually includes aided word and sentence tests, often in background noise, and some centres add cognitive screening for older adults.6 Imaging of the inner ear and nerve is part of planning.
Vaccination. People with implants have a higher risk of bacterial meningitis, especially pneumococcal meningitis. The US Centers for Disease Control and Prevention (CDC) recommends pneumococcal vaccination and advises completing doses at least two weeks before surgery.10
Surgery. The operation is done under general anaesthesia and takes about two hours.12 The surgeon makes an incision behind the ear, opens the mastoid bone, places the receiver in a pocket against the skull and inserts the electrode array into the cochlea. Many people go home the same day. In England, electrode position is confirmed by imaging or electrical testing during or soon after surgery.13
Activation, mapping and results timeline
| Stage | What usually happens |
|---|---|
| First days | Dressing care; washing around the incision usually resumes after a day or two12 |
| About 1 week | Wound check and stitch removal12 |
| 2–4 weeks | Switch-on: the external processor is fitted and first programmed1112 |
| First 4–6 weeks after switch-on | Several programming sessions; early sound is often not understood12 |
| 1–6 months | Most people notice improvement around a month after activation; fuller benefit may take three to six months11 |
| Long term | Programming reviews every 6–12 months or as needed12 |
Mapping (programming) sets how much electrical current each electrode delivers so that sound is audible but comfortable. Maps change as the brain adapts. In England, at least three progress assessments are required in the first year.13 Children usually start auditory therapy soon after switch-on; adults typically start after about a month of listening.12
Outcomes vary widely.3 In a study of 2,251 adults who lost hearing after learning language, duration of severe-to-profound loss, age, cause and implant experience all influenced results, and people with long-standing deafness were less likely to keep improving.8
How long the implant lasts and long-term follow-up
The internal implant is intended to stay in place for life, though devices can fail and need replacement surgery.311 External processors typically last five to ten years;11 NHS England expects upgrades on average every five years where clinically appropriate.13
Follow-up is lifelong. The NHS England service specification includes ongoing programming, spares and repairs, a target of resolving repairs within two working days, an appointment within seven working days when failure is suspected, and re-implantation if needed. It also requires records of every programme installed.13 This is why programming access matters if you are treated abroad.
Pain and comfort
Nothing is felt during the operation because it is done under general anaesthesia.12 Afterwards, soreness around the incision and numbness around the ear are recognised; increasing pain, swelling, discharge or fever should be reported.12 Dizziness can occur in the early period.3
MRI scanning with the magnet in place can cause pain.4 Published patient information gives little detail on typical pain levels, so ask what pain relief the team usually advises.
Risks and complications
Expected temporary effects: wound soreness, swelling, numbness around the ear and short-lived dizziness.12
Recognised complications: loss of residual hearing in the implanted ear, tinnitus (ringing or buzzing), vertigo, taste disturbance from injury to the taste nerve, wound infection, and device failure needing further surgery.312 A 2026 meta-analysis of 6,374 recipients aged 65 or over found a pooled major surgical complication rate of 2.43% and no 30-day deaths, but most included studies were retrospective and minor-complication estimates were very uncertain.14
Rare serious complications: meningitis, facial nerve injury causing temporary or permanent facial weakness, and leakage of inner-ear fluid or cerebrospinal fluid.3
How strong is the evidence?
| Claim | Vireon assessment | What supports it | Important limitation |
|---|---|---|---|
| Implants improve sound and speech access for selected severe-to-profound loss | Strong | NICE appraisal; FDA device approvals57 | Benefit varies widely between individuals |
| Duration of deafness, age and cause influence outcome | Moderate | Multicentre study of 2,251 adults8 | Retrospective; cannot predict one person’s result |
| Major surgical complications are uncommon in older adults | Limited | 2026 meta-analysis of 41 studies14 | Mostly retrospective single-centre cohorts; reporting bias likely |
| Pneumococcal vaccination reduces meningitis risk | Moderate | CDC recommendation10 | Does not remove all meningitis risk |
| Frequency of MRI-related adverse events | Uncertain incidence | FDA safety communication4 | FDA states the frequency is unknown |
Most outcome evidence is observational rather than randomised. Test methods differ between centres and labels rarely specify them,6 so published percentages are hard to compare.
MRI and device distinctions
Implants are labelled either MR Unsafe (never scanned) or MR Conditional (scanned only under the manufacturer’s conditions).4 Some MR Conditional implants require the magnet to be removed surgically before a scan and replaced afterwards; others use a head splint or bandage kit, and newer designs allow the magnet to rotate to reduce twisting forces. Reported events include pain, magnet displacement, skin breakdown, heating and repeat surgery.4
Know your implant’s brand and model, carry the implant card, and tell the scanning team before any MRI.4 Treatment-specific red flags include a provider who cannot name the device model and its MRI status, offers no implant card, or has no plan for programming after you leave.
Cost drivers and what a quote should include
- Device manufacturer and model; one or two implants.
- Pre-operative audiology, imaging, team assessment and vaccinations.
- Surgery, anaesthesia and hospital stay.
- Switch-on and how many programming sessions are included, and for how long.
- Rehabilitation or auditory therapy.
- Warranty, repairs, batteries, spare parts and future processor upgrades.
- Management of complications and device failure, including re-implantation.
Ask for every item in writing; see also what a treatment quote should include.
If you are travelling for treatment
- Assessment, imaging and hearing tests need to be done in person, ideally before travel is booked.
- Wound review is usually around a week after surgery and switch-on two to four weeks after,1112 so plan either a longer stay or switch-on at home.
- Before surgery, confirm in writing that a centre near home will programme and repair your specific manufacturer’s device. Programming software and parts are brand-specific.
- Bring home the operation note, device model and serial numbers, implant card and a copy of every programme.413
- Ask the surgical team when flying is reasonable for you.
Questions worth asking a clinician
- What is causing my hearing loss, and does imaging show a usable cochlea and nerve?
- How likely am I to lose remaining hearing in the implanted ear?
- Which device do you propose, and what is its MRI status?
- Who will programme it in the first year and for life?
- What outcomes do your patients with a similar history achieve?
Frequently asked questions
Does cochlear implant surgery hurt?
The operation itself is done under general anaesthesia, so you are asleep.12 Soreness and numbness around the ear afterwards are common; worsening pain should be reported.
How soon will I hear?
Nothing is heard through the implant until switch-on, usually two to four weeks after surgery. Most people notice improvement about a month after activation, with fuller benefit over three to six months.11
When can I work, exercise, drive and fly?
There is no single published timetable; your surgical team will advise based on healing and any dizziness. The external processor is removed for swimming and bathing, and some contact sports may need to be avoided.11
How long does an implant last?
The internal part is intended to last for life, while processors are typically replaced every five to ten years.11 Programming continues indefinitely.
Can I have an MRI scan?
Sometimes, depending on the device. Only MR Conditional implants can be scanned, under the manufacturer’s conditions, sometimes after magnet removal.4
Will I need one implant or two?
Most UK adults are offered one. NICE recommends simultaneous implants in both ears for children and for adults with additional reliance on hearing, such as blindness.5
Bottom line
A cochlear implant is a lifelong relationship with a device and a programming team, not a single operation. Understanding why hearing was lost, and whether the nerve can carry the signal, comes before any decision. If surgery happens far from home, secure local programming and repair before you commit.
Related reading
Sources
- National Institute on Deafness and Other Communication Disorders (NIDCD). Cochlear implants. National Institutes of Health; undated. https://www.nidcd.nih.gov/health/cochlear-implants. Accessed 5 November 2026.
- US Food and Drug Administration. What is a cochlear implant? FDA; 2018. https://www.fda.gov/medical-devices/cochlear-implants/what-cochlear-implant. Accessed 5 November 2026.
- US Food and Drug Administration. Benefits and risks of cochlear implants. FDA; 2021. https://www.fda.gov/medical-devices/cochlear-implants/benefits-and-risks-cochlear-implants. Accessed 5 November 2026.
- US Food and Drug Administration. Cochlear implants and MRI safety. FDA; 2021. https://www.fda.gov/medical-devices/cochlear-implants/cochlear-implants-and-mri-safety. Accessed 5 November 2026.
- National Institute for Health and Care Excellence. Cochlear implants for children and adults with severe to profound deafness (TA566). NICE; 2019. https://www.nice.org.uk/guidance/ta566 (PDF: https://www.nice.org.uk/guidance/ta566/resources/cochlear-implants-for-children-and-adults-with-severe-to-profound-deafness-pdf-82607085698245). Accessed 5 November 2026.
- Zwolan TA, Basura G. Determining cochlear implant candidacy in adults: limitations, expansions, and opportunities for improvement. Seminars in Hearing; 2021;42(4):331–341. https://doi.org/10.1055/s-0041-1739283 (full text: https://pmc.ncbi.nlm.nih.gov/articles/PMC8660165). Accessed 5 November 2026.
- US Food and Drug Administration. Premarket approval supplement P000025/S134: MED-EL Cochlear Implant System (expanded paediatric indications). FDA; 2025. https://www.accessdata.fda.gov/cdrh_docs/pdf/P000025S134B.pdf. Accessed 5 November 2026.
- Blamey P, Artieres F, Başkent D, et al. Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants: an update with 2251 patients. Audiology and Neurotology; 2013;18(1):36–47. https://repository.bionicsinstitute.org/items/fd76549d-e6e0-443b-a23a-436e5f44799d. Accessed 5 November 2026.
- WHO. Deafness and hearing loss (fact sheet). WHO; 2026. https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss. Accessed 5 November 2026.
- US Centers for Disease Control and Prevention. Pneumococcal vaccination for people with cochlear implants. CDC; 2026. https://www.cdc.gov/pneumococcal/vaccines/cochlear-implants.html. Accessed 5 November 2026.
- Cleveland Clinic. Cochlear implants. Cleveland Clinic; 2026. https://my.clevelandclinic.org/health/treatments/4806-cochlear-implants. Accessed 5 November 2026.
- Johns Hopkins Medicine. Cochlear implant surgery. Johns Hopkins Medicine; undated. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/cochlear-implant-surgery. Accessed 5 November 2026.
- NHS England. Service specification D09/S/a: Cochlear implantation services (adults and children). NHS England; 2023. https://www.england.nhs.uk/wp-content/uploads/2013/05/D09sa-cochlear-implantation-services.pdf. Accessed 5 November 2026.
- Laidlaw M, Khaw D, Reid M, Rajiv S, Gerard JM. Perioperative complication rates in elderly cochlear implant recipients: a systematic review and meta-analysis. Australian Journal of Otolaryngology; 2026;9. https://doi.org/10.21037/ajo-2025-1-87 (full text: https://www.theajo.com/article/view/5173/html). Accessed 5 November 2026.
- Penn Medicine Otorhinolaryngology – Head and Neck Surgery. Auditory brainstem implantation. Penn Medicine; 2020. https://pennmedicine.org/departments-and-centers/otorhinolaryngology/about-us/newsletters/archive/2020-newsletters/auditory-brainstem-implantation. Accessed 5 November 2026.
- National Institute on Deafness and Other Communication Disorders (NIDCD). Assistive devices for people with hearing, voice, speech, or language disorders. National Institutes of Health; 2019. https://www.nidcd.nih.gov/health/assistive-devices-people-hearing-voice-speech-or-language-disorders. Accessed 5 November 2026.
Article history
- — First published.